After donation to the U.S., Gilead outlines plans to distribute COVID-19 drug worldwide

Gilead on Tuesday said it is negotiating with overseas drug manufacturers to license its coronavirus treatment remdesivir in an effort to speed global access. Agreements covering Europe and Asia would extend through 2022, Gilead said, while longer-term pacts for developing countries are also being worked out.